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Background. The Epstein-Barr virus (EBV) was used as an agent of B lymphocyte proliferation for subsequent diagnosis of
lysosomal storage disease. Due to the constant handling of long-preserved samples in our cell bank, we decided to observe the
behavior and then compare cultured and frozen samples for at least one year’s cryopreservation. Methods.T w e n t y - ﬁ v es a m p l e s
from healthy individuals were used to assess the possible changes in activity of enzymes β-galactosidase, β-glucosidase, α-
iduronidase, α-galactosidase, and α-glucosidase. Transmission electron microscopy was used to conﬁrm cell transformation of
B lymphocytes into EBV-infected cells, generating lymphoblastoid cell lines. Results. Transmission electron microscopy ﬁndings
conﬁrmed previous reports in the literature that is, signiﬁcant and evident morphological changes in the nucleus occur after day
12 and the consequent cell transformation into EBV-infected cells. After thawing and subsequent treatment with the ﬁve enzymes
utilized, we observed no signiﬁcantchanges in samplescryopreserved for more than one year, ascompared to samples cultured for
12 days.
1.Introduction
Inborn errors of metabolism (IEM) is the term used to refer
to a set of genetically determined autosomal recessive dis-
easesthat includearound 500diﬀerentdysfunctions and that
account for 10% of genetic diseases. IEM have been divided
into groups, according to the repercussions to cells and to
the associated metabolic defect [1]. One of these groups of
diseases includes lysosomal storage diseases (LSD), in which
abnormal amounts of built-up substrates are stored in cells,
usually leading to changes in cell architecture and function.
These dysfunctions are generally caused by a deﬁciency in
specific enzymes, among which β-galactosidase, β-glucos-
idase, α-iduronidase, α-galactosidase, and α-glucosidase,
whose deﬁcit may cause GM1-gangliosidosis, Gaucher, muc-
copolysaccharidosis type 1, and Fabry and Pompe diseases,
respectively.
It is believed that early treatment may lessen the chances
of irreversible damage like hepatomegaly and/or splenomeg-
aly, skeletal changes, and signiﬁcant alterations in the central
nervous system [2]. Physicians establish a preliminary diag-
nosis based on clinical features. This initial diagnosis is then
conﬁrmedbylaboratory analysis, whichisusuallyperformed
using leukocytes, though ﬁbroblasts and whole blood (blood
spots) may also be used, and, in some conditions, plasma
or urine. However, these biological specimens degenerate
with time, compromising the enzyme test or its repetition
[3].
When it is necessary to store cells for longer periods for
enzyme activity analysis, cultivated ﬁbroblasts are used,
though these have limited lifespan, and suﬀer the eﬀects
of aging and modiﬁcations of enzyme activities during
senescence [3, 4]. Moreover, the discomfort as the collection,
the lack of speciﬁc knowledge as to the correct collection
procedure observed in some laboratories, and the even
greatertroubleinrecollecting material arenegative aspectsof
theutilizationofﬁbroblastsobtainedfromskinfragments.In
this scenario, the technique is used by the few professionals
who are virtually acquainted with the standard proceduresof
this important diagnosis tool [5].2 Journal of Biomedicine and Biotechnology
Alternatively, lymphoblastoid cell lines (LCLs) obtained
from lymphocytes B in the peripheral blood ﬂow incu-
bated with the Epstein-Barr virus (EBV) may be used. In
comparison with the skin ﬁbroblast lines, this technique
oﬀers a few advantages: (a) faster collection of material, (b)
lower cytogenetic variation, (c) faster cell proliferation with
no senescence, (d) growth in suspension, (e) massive cell
material proliferation, (f) freezing and subsequent reestab-
lishment ofcultureswith highersuccess rates as compared to
ﬁbroblasts, (g) low volumes (2 to 3mL, or less) of peripheral
blood required, and (h) stability of the karyotype and of
phenotypical expression [3, 6–8].
The EBV belongs to the Herpesviridae family and is the
etiological agent of infectious mononucleosis [9], among
other diseases such as Burkitt lymphoma, Hodgin’s disease,
andT-cell lymphoma [10].Similarly tosome LSDcells, EBV-
transformed lymphocytes likewise form signiﬁcant cyto-
plasm vacuoles caused by immune response [6].
Our research group has shown that no signiﬁcant chan-
ges in enzyme activities are observed, before and after LSD
freezing, within a 180-day cryopreservation period [11]. In
addition to the shorter culture time (12days), the mainte-
nance of activities along time would guarantee the subse-
quent repetition of the procedure, if necessary.
The present study evaluates the activity of the ﬁve lyso-
somal hydrolases mentioned above after a 1-year cryopreser-
vation period and tested the eﬃciency of the LCL transfor-
mation method [12] using transmission electron microscopy
(TEM).
2.Materialsand Methods
2.1. Blood Collection. Twenty milliliter peripheral blood
samples were collected from 25 healthy individuals using
heparinized tubesfor subsequentculture ofperipheral blood
mononuclear cells (PBMCs). These cells were obtained by
Fycoll-Histopaque (Sigma, St. Louis, Mo, USA) gradient
centrifugation. The protocol was approved by both scientiﬁc
and ethics committees (ClinicalH o s p i t a lo fP o r t oA l e g r e ,
HCPA, Porto Alegre, Brazil), and written informed consent
was obtained from all subjects.
2.2. Preparation and Conservation of EBV B95’8 Cells. EBV
B-95
 8 cells were acquired from the Cell Bank of the State
of Rio de Janeiro, from the Federal University of the State of
Riode Janeiro, and frozen in liquidnitrogen upon use. These
cells were then cultured to the required volume in RPMI-
1640 medium supplemented with 20% fetal calf serum and
exposedtoaCO2-freeatmospherebyclosingthecultureﬂask
for 5 to 7days. Next, adherent cells were detached using Cell
Scraper(Corning, NewYork, NY, USA)and thenﬁltered in a
0.22-μm ﬁlter (Millipore, Bedford, Mass, USA).
2.3. Mononuclear Cell Culture. After separation of PBMCs,
cells were counted in a Neubauer chamber and adjusted to
9 × 106 cells per culture ﬂask. Next, 2μg/mL cyclosporine
A (CyA) (Sandimmum, Sandoz, East Hannover, NJ, USA)
and 1mL of the viral particle were added. The viral particle
was obtained using the EBV B-95’8 strain. The RPMI-
1640 medium was replaced after 4 and after 8days, with
CyA 1μg/mL supplementation. On day 12, cultures were
centrifuged (400×g, 10min) in PBS medium, after which
cells were collected. Then, half of the collected cells were
submitted to measurement of enzyme activity and half was
cryopreserved for one year.
2.4. Freezing and Thawing of Samples. Cells were gradually
frozen in fetal bovine serum supplemented with 10% DMSO
in a freezing container immersed in isopropanol (Nalgene
Nunc Int., Rochester, NY, USA). Samples were kept in the
freezer at −80◦C for 24h and then conserved in liquid
nitrogen upon enzyme activity evaluation.
2.5. Electron Microscopy. After the separation of the mon-
onuclear fraction by Fycoll-Histopaque (Sigma, St. Louis,
Mo, USA) gradient centrifugation, cells were grouped as
lymphocytes and EBV-infected lymphocytes. Pellet cells of
the peripheral blood were ﬁxed in a mixture formed by
paraformaldehyde 4% and glutaraldehyde 2.5% buﬀered
with 0.1M phosphate (pH 7.3) at room temperature and
postﬁxed in phosphate-buﬀered OsO4,d e h y d r a t e di n
ascending alcohol and acetone, and embedded in araldite
(Durcupan ACM, Fluka). Ultrathin sections (70nm) were
stained with 2% uranyl acetate followed by lead citrate and
examined under JEM 1200 EX II (CME –UFRGS).
2.6. Assessment of Lysosomal Acid Hydrolases. Analyses of
human lysosomal acid hydrolases were performed in lym-
phocytes and LCLs on the 12th day of culture and after
365days of freezing. β-glucosidase activity was evaluated
using a well-established method [13], which utilizes 4-meth-
ylumbelliferyl-β-D-glucoside (Sigma) as synthetic substrate,
together with sodium taurocholate (Sigma), under standard
conditions(pH 5.5and 37◦C). Activitiesofenzymes β-galac-
tosidase [3]a n dα-iduronidase [14] were estimated by incu-
bation with 4-methylumbelliferyl-β-D-galactoside (Sigma)
and 4-methylumbelliferyl-α-L-iduronide (Sigma) as sub-
strates, respectively, under standard conditions (pH 4.0 and
pH 2.8, resp., at 37◦C).Furthermore, α-galactosidase activity
was evaluated according to another classical method [15],
which uses4-methylumbelliferyl-α-D-galactoside (Sigma)as
synthetic substrate together with citrate phosphate (Sigma),
under standard conditions (pH 4.8 and 37◦C). Activity of
the enzyme α-glucosidase was evaluated according to again
anothermethod[16],which uses4-methylumbelliferyl-α-D-
glucoside (Sigma) as the synthetic substrate, together with
acetate (Sigma) in standard conditions (pH 4.0 and 37◦C).
Fluorescence was evaluated by spectroﬂuorometry (365nm
excitation and 450nm emission). Data are expressed as
nmol/h/mg of protein [17].
2.7. Statistical Analysis. Data were reported as mean ± SD.
The activities of the ﬁve enzymes evaluated on day 12
in culture and immediately on day 325 in freezing were
compared using the Student’s t-test (P<. 05) in the software
GraphPad Prism 5.Journal of Biomedicine and Biotechnology 3
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Figure 1: Evaluation of LCL’s transformation by electron mi-
croscopy: (a) (0.5μm), (b) (0.5μm), (e) (1μm)—Lymphocytes
before transformation. (c) (300nm), (d) (300nm), (f) (1μm)—
Lymphocytes after transformation. Bn: binucleation, c: cytoplasm,
m: mitochondria, n: nucleus, re: endoplasmic reticulum.
3.Results
3.1. Evaluation of Cell Transformation. Cell transformation
was successful in 100% of cases, since the material collected
from all 25 subjects was successfully transformed.
Figures 1(a), 1(b),a n d1(e) show that lymphocytes pre-
sented a morphologically well-deﬁned nucleus, with pre-
served mitochondria. Also, endoplasm reticuli, ribosomes,
and Golgi apparatus were well organized in the cytoplasm.
Figures 1(c), 1(d),a n d1(f) from lymphocytes cultured with
EBV show a higher number ofcell organelles, apart from sig-
niﬁcant morphological changes such as larger mitochondrial
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Figure2:EnzymaticanalysisofacidhydrolasesfromLCLs.Dataare
expressed as mean + standard deviation. β-gluco: β-glucosidase, α-
gal: α-galactosidase, β-gal: β-galactosidase, α-gluco: α-glucosidase,
and α-iduro: α-iduronidase.
having disorganized cristae, electrolucid structures (ﬁlled
with material), numerous lysosomes, binucleated cells, and
myelin bodies. These features conﬁrm the transformation of
lymphocytes by the EBV.
3.2. Assessment of Lysosomal Acid Hydrolases. No statisti-
cally signiﬁcant changes were observed between the results
obtained for both times (Figure 2). After the 1-year cryop-
reservation period of samples, α-galactosidase activity was
similar to that measured on day 12 of culture (55.9 ± 29.6
and 46.4 ± 11.5, resp.). The same was observed for the
other enzymes: β-glucosidase (31.7 ± 17.5 and 35.8 ± 13.8,
resp.), β-galactosidase (166.4 ± 68.7 and 163.7 ± 60.9),
α-glucosidase (5.1 ± 2.7 and 4.4 ± 1.9, resp.), and α-
iduronidase (33.1 ± 16.2 and 27.6 ± 10.3, resp.).
4.Discussion
Two previous studies conducted by our research group have
demonstrated the eﬀectiveness of this protocol in culturing
lymphocytes transformed with EBV in a short period of
time (12days) [11, 18]. Since the culturing of transformed
lymphocytes is less labor intensive and the material (blood)
is more easily obtained—as compared to ﬁbroblasts [3], we
decided to further investigate the inﬂuence of lymphocyte
cryopreservation times on the activity of lysosomal hydro-
lases and to evaluate the eﬃciency of the transformation of
these cells using the EBV.
In the present study, we evaluated ﬁve enzymes largely
employed in the diagnosis of LSDs of common occurrence.
According to Staretz-Chacham et al. [19], the methods used
in our study are sensitive and selective for the measurement
of these enzymes activities in the diagnosis of LSDs. The
activity of all enzymes remained essentially constant after4 Journal of Biomedicine and Biotechnology
the 1-year cryopreservation period. This indicates that these
samplesmay besafely handled afterthisperiodoftime.Since
blood collection is a less invasive approach as compared to
skinbiopsy,suchresult shows great promise.The consistency
in enzyme activities has been demonstrated in 30- and 6-
month cryopreservation periods [11, 18].
Cell culture was followed up throughout the cell culture
period by observing the formation of clusters, which are, ac-
cording to the literature, clear indicators of cell transforma-
tion[20].These clustersincreased withtime,uponbecoming
visible to the naked eye.
Transmission electronmicroscopy aﬀordedto detectmy-
elinoid bodies, binucleated cells, nuclear invagination, and
cytoplasm vacuoles in EBV-infected cell cultures (Figure 1).
These ﬁndings conﬁrm the successful transformation of
lymphocytes by the EBV. This transformation, side by side
with the fact that enzyme activities remained stable after
the 1-year cryopreservation period cells were submitted to,
aﬀords an excellent approach to diagnose LSDs.
The presence of myelinoid bodies after the transforma-
tion of cells by the EBV has been observed in some LSDs,
as reported in the literature [21–23]. This was also seen in
normal cells in the present study. Disorders like Niemann-
Pick type b and c [7, 21] were also characterized by the
formation of these myelin bodies in lymphocytes.
Lymphocyte binucleation (Figure 1(d)) has been report-
ed instudies using lymphocytesofmyeloma patients [24]. In
ourstudy, the cell culturestransformed by EBV B-95
 8s t r a i n
originatedfrom EBV-infectedlymphocytesalsoexhibitedthe
phenomenon.
The results obtained in the present study are in agree-
ment with the ﬁndings obtained by our research group in
previous studies [11, 18]. This means that the freezing of
samples according to a less invasive method which aﬀords
the easy obtainment of material allows to conduct a reliable
enzyme analysis even when the sample is frozen for a long
period of time.
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